TXG
10x Genomics Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||
| Capital Expenditures | 5.9M | 12.4M | 48.6M | 131.7M | 101.3M | 36.7M | 42.7M | 6.3M | 3.8M |
| Acquisitions | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||
| Free Cash Flow | 130.1M | -5.7M | -63.8M | -165.3M | -122.7M | -254.6M | -8.1M | -82.7M | -14.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — |